Microbiota: a key orchestrator of cancer therapy

By S. Roy, G. Trinchieri. Nature Reviews. Cancer, 2017

785 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic (2018, background): “inflamed gene expression profile (GEP) [26], immune gene expression signatures [27, 28], as well as description of the microbiome [29-31] also represent emerging predictive”
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis (2019, background): “In addition, alterations in gut microbes in response to critical immune signaling contribute to the illnesses in intestine and distal organs, such as inflammatory bowel disease, autoimmune disease, and various types of cancer [8, 9].”
The gut microbiome: Relationships with disease and opportunities for therapy (2018, background): “Recent evidence has emphasized the importance of enteric microbiota in modulating response to various forms of cancer immunotherapy (Roy and Trinchieri, 2017; Zitvogel et al., 2018).”